<DOC>
	<DOCNO>NCT00207168</DOCNO>
	<brief_summary>To assess compliance daily dose assess benefit term potency safety well impact adherence quality life .</brief_summary>
	<brief_title>To Assess Compliance With Once-daily Regimen Lamivudine , Efavirenz Didanosine</brief_title>
	<detailed_description />
	<criteria>18 old , require lab result , currently take two propose daily arm medication medication administer twice daily woman child bear potential . virological failure , serious medical condition , know toxicity daily arm medication , lab abnormality , woman pregnant/breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>